News

Home > Daily News  >
OFT to study control of entry
| Search


OFT to study control of entry
(3 October 2001)

The Office of Fair Trading is to examine the control of entry regulations, which govern how National Health Service dispensing contracts are granted, as part of a review of the whole market for pharmacy services, the director general for fair trading, John Vickers, announced on 3 October.

A spokesman for the OFT told The Journal that the review will cover the whole pharmacy market. This could include the registration of pharmacy premises with the Royal Pharmaceutical Society.

"The aim of the inquiry is to look at what the current regulations are intended to achieve and whether they are achieving that. We will look at the effects on consumers and the effects on the sale of over-the-counter medicines. We will also look at the current state of profitability of community pharmacies and the entry and exit to the market."

The inquiry will involve a team of six to 12 investigators from the OFT's markets and policy initiatives division holding discussions with interested parties. Outside expertise may also be brought in. The inquiry is expected to last between six and 12 months. However, if the OFT feels that enforcement action or a referral to the Competition Commission is necessary then it could issue a direction to that effect within two to three months.

The OFT says: "It is important for customers that a convenient [pharmacy] service is available, because many want to purchase OTC medicines with the benefit of a pharmacist's advice, or need frequent repeat prescriptions. Restrictions on where chemists can open potentially have an effect on competition and not only on dispensing prescriptions. The system will be reviewed to see how the present restrictions affect competition and consumers and whether there are alternative ways of achieving the public interest objectives behind the present arrangement."

The OFT has five options for its inquiry. It can recommend enforcement action by the OFT, make a reference to the Competition Commission, make recommendations to the Government for changes to laws or regulations, suggest consumer awareness campaigns, or issue a clean bill of health.

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal